Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Holds Annual mPower Customer Conference
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Mitchell
News Release
Mitchell Congratulates 2018 mPower Award Winners
Celebrating customers for delivering an excellent customer experience through business innovations
Workers' Comp
Article
StateWatch: Bill Review October 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
Conference
The SEMA Show 2018
The SEMA Show is the premier automotive specialty products trade event in the
Mitchell
Article
2019 CMS Medicare Payments: Proposed Changes and What They Mean for P&C Insurers
Several states in auto and workers’ compensation claims administration have adopted the Centers of Medicare and Medicaid Services’ (CMS) fee schedu
Workers' Comp
News Release
Genex Services Extends Care Continuum Through PCS Acquisition
Specialty network provider helps Genex expand and streamline its medical management services